ROLE OF ADAM-12/SYNDECAN-4 SIGNALLING PATHWAY IN VENTRICULAR REMODELLING IN RATS WITH ALCOHOLIC CARDIOMYOPATHY

Objectives Chronic excessive consumption of alcohol causes cardiac remodelling and eventually leads to alcoholic cardiomyopahty (ACM). A disintegrin and metalloproteinase-12 (ADAM-12) is involved in degradation of extracellular matrix using syndecan-4 as a primary cell surface receptor. This study a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart (British Cardiac Society) 2012-10, Vol.98 (Suppl 2), p.E66-E67
Hauptverfasser: Li, Jianqiang, Li, Weimin, Li, Yue, Xue, Jingyi, Zhao, Jiyi, Kong, Yihui, Guo, Hong, Sheng, Li, Gong, Yongtai
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Chronic excessive consumption of alcohol causes cardiac remodelling and eventually leads to alcoholic cardiomyopahty (ACM). A disintegrin and metalloproteinase-12 (ADAM-12) is involved in degradation of extracellular matrix using syndecan-4 as a primary cell surface receptor. This study aimed to investigate the role of ADAM-12/syndecan-4 signalling pathway in ventricular remodelling of ACM. Methods Fifty healthy Wistar rats were randomly divided into a control group (n=20) and an ACM group (n=30). Animals in the ACM group were given 10% alcohol ad libitum as the drinking water and 60% alcohol (5 ml kg−1 once per day) by intragastric administration in the first week; 10% alcohol ad libitum as the drinking water and 60% alcohol (10 ml kg−1 twice per day) by intragastric administration in the second week; 20% alcohol ad libitum as the drinking water and 60% alcohol (15 ml kg−1 twice per day) by intragastric administration from week 3 to week 16; and 30% alcohol ad libitum as the drinking water and 60% alcohol (15 ml kg−1 twice per day) by intragastric administration from week 17 to month 6. Animals in the control group received purified drinking water in the same regimen with alcohol treatment. Before and 6 months after initiating the study, left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), and fractional shortening (FS) were assessed by echocardiography. Histopathology and ultrastructure of myocardium were examined with light and electron microscopy; mRNA expressions of ADAM-12 and syndecan-4 were evaluated by real-time PCR; and protein expressions of ADAM-12 and syndecan-4 were analysed using immunohistochemistry and western blot, respectively. The expression of TIMP-3, an endogenous inhibitor of ADAM-12, was also tested. Results Following 6 months of alcohol feeding, LVEF and FS were reduced p
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2012-302920a.164